A randomized trial of adjuvant chemotherapy in resected stage I lung adenocarcinoma with high SUV index. JNETS 1201

A randomized trial of adjuvant chemotherapy in resected stage I lung adenocarcinoma with high SUV index. JNETS 1201 - Adjuvant chemotherapy in lung adenocarcinoma with high SUV index. JNETS 1201

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007790

Enrollment

460

Registered

2012-04-20

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Control n=230(stage IA: no chemotherapy, stage IB: UFT) Trial n=230 (stage IA: UFT, stage IB: chemotherapy with CDDP or CBDCA)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: p-stage I lung adenocarcinoma with SUV index with 1 or more.

Exclusion criteria

Exclusion criteria: non-p-stage I lung adenocarcinoma with SUV index with 1 or more.

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Disease-free survival	—

Countries

Japan

Contacts

Public ContactSatoshi Shiono

Yamagata Prefectural Central Hospital Department of thoracic surgery

023-685-2626

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026